Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research Medical Dialogues Bureau28 March 2020 7:22 AM GMTThe trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare...
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Farhat Nasim10 Nov 2019 4:30 AM GMTNew Delhi: Drug firm, Laurus Labs Ltd. recently said in a filing that the US health regulator has issued two observations after the inspection of its...
Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units Medical Dialogues Bureau6 Sep 2019 7:33 AM GMTThe establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
USFDA completes inspection at Laurus Labs' AP unit Medical Dialogues Bureau19 July 2019 4:32 AM GMTMumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria Farhat Nasim12 March 2019 6:31 AM GMTHydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
Laurus Labs gets tentative USFDA approval for HIV combo drug Farhat Nasim4 Feb 2019 4:00 AM GMTHyderabad: Indian pharmaceutical player, Laurus Labs said Sunday it has received tentative approval from the United States Food and Drug...
